Patents by Inventor Shelley A. Maves

Shelley A. Maves has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides that inhibit complement activation
    Patent number: 7348401
    Abstract: The present invention relates to compositions, including pharmaceutical compositions that inhibit complement activation, and contain amino acid sequences X1-X2-X3-W-E-X4-X5-X6 and/or Z1-C1-Z2-P-Z3-Z4-C2-Z5 as described. The invention further relates to methods of inhibiting complement activation in vivo or ex vivo by administering a pharmaceutical composition as described herein.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: March 25, 2008
    Assignee: Innate Biotech, Inc.
    Inventors: Richard J. Johnson, Shelley A. Maves
  • Peptides that inhibit complement activation
    Publication number: 20050090448
    Abstract: The present invention relates to compositions, including pharmaceutical compositions that inhibit complement activation, and contain amino acid sequences X1-X2-X3-W-E-X4-X5-X6 and/or Z1-C1-Z2-P-Z3-Z4-C2-Z5 as described. The invention further relates to methods of inhibiting complement activation in vivo or ex vivo by administering a pharmaceutical composition as described herein.
    Type: Application
    Filed: September 10, 2004
    Publication date: April 28, 2005
    Inventors: Richard Johnson, Shelley Maves
  • Peptides that promote complement activation
    Publication number: 20050090447
    Abstract: The present invention relates to compositions, including pharmaceutical compositions that promote complement activation, and contain a polypeptide X1-C-X2-X3-X4-X5-X6-X7-X8-C-X9 as described. The invention further relates to a method of promoting complement activation in a patient by administering a pharmaceutical composition as described herein. Further provided are a wound dressing and an anti-tumor cell antigen antibody formulation containing pharmaceutical compositions of the present invention.
    Type: Application
    Filed: September 10, 2004
    Publication date: April 28, 2005
    Inventors: Richard Johnson, Shelley Maves